1. According to Omegaven® contraindications (serious bleeding disorders, acute life-threatening condition, including acute shock, acute myocardial infarction, acute stroke, acute emboli, and coma). 2. Known hypersensitivity to Omegaven or any of the ingredients. 3. Participation in any clinical research study evaluating an investigational medicinal product (IMP) within 3 months prior to screening. 4. Pregnancy and breastfeeding.

1. According to Omegaven® contraindications (serious bleeding disorders, acute life-threatening condition, including acute shock, acute myocardial infarction, acute stroke, acute emboli, and coma). 2. Known hypersensitivity to Omegaven or any of the ingredients. 3. Participation in any clinical research study evaluating an investigational medicinal product (IMP) within 3 months prior to screening. 4. Pregnancy and breastfeeding.